Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naïve Chronic Hepatitis B Patients in Korea

BACKGROUND: The occurrence of hepatocellular carcinoma (HCC) is a major concern during antiviral therapy for chronic hepatitis B. There are conflicting opinions regarding the effects of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on HCC prevention. We assessed these two antiviral medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, HeeKyoung, Seo, Gi Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042481/
https://www.ncbi.nlm.nih.gov/pubmed/33847080
http://dx.doi.org/10.3346/jkms.2021.36.e89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042481/
https://www.ncbi.nlm.nih.gov/pubmed/33847080
http://dx.doi.org/10.3346/jkms.2021.36.e89

Ejemplares similares